Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.

Justa Friebus-Kardash Ute EisenbergerJessica AckermannAndreas KribbenOliver WitzkeJürgen WenzelHana RohnMelanie Fiedler

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

Prevalence of active HEV infection is important in renal transplant patients without signs of nosocomial infection. Ribavirin treatment was safe and effective.

Keyphrases

risk factors
newly diagnosed
combination therapy
cystic fibrosis
multidrug resistant
replacement therapy
acinetobacter baumannii
smoking cessation
patient reported outcomes